NEW YORK (360Dx) – Owlstone Medical said this week that it has initiated the Pan Cancer trial for Early Detection of Cancer in Breath, a "large-scale clinical study" that will evaluate the use of Owlstone's Breath Biopsy platform for the early detection of multiple cancer types.

The trial is being conducted in collaboration with a team of cancer researchers at the Cancer Research UK Cambridge Center, the University of Cambridge, and Cambridge University Hospital's NHS Foundation Trust.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.